| ceocfocorporatebriefs.com | |
| 网站标题： | Urovant Sciences | Jim Robinson | Overactive Bladder Treatment |
| 网站简介： | OAB treatment | GEMTESA | Urovant Sciences: Successful Launch of First Commercial Product Enables Company’s Growth and Evolution in Addressing Unmet Needs in Urology | CEO Interviews 2021 | Medical Companies |
| 关键字： | therapies for urological conditions GEMTESA for patients with OAB vibegron treatment for urge urinary incontinence treatments for urinary leakage episodes treatments urinary urgency treatm |
1/1 [1]